All Type of News
Imported drug insurance plan requested one year postponement.
The Korea Pharmaceutical Trade Association (KPhTA) presented an official position paper to the MOHW titled "Proposal for insurance drug pricing of imported drugs" indicating that imported drugs under the current insur...
Mr. Kim Hee-sun nominated to head of MOHW planning and administration office.
The MOHW will nominate Mr. Kim Hee-sun, the deputy administrator of KFDA, as the head of the planning and administration office (lst grade of government official), Mr. Lee Kyung-ho, Health and Welfare secretary of the...
MOHW and KFDA concerned drug equivalency issue raised by civic groups.
The civic group earlier enticed an agreement on the medical and pharmacy separation system from each different interested group. In this connection, one of sensitive issues raised by the civic group that the MOHW and ...
Insurance drug price slash to hold possibly for long time.
The government price reduction plan for insurance drugs as scheduled to take effect from coming July 1, this year goes very likely to hold back for quite a long period of time in line with the implementation of new in...
Drug industry alert to public prosecutor's inspection on irrational drug deals.
Recently the public prosecutor investigated hospitals on bribery and rebate scandals in connection with hospital purchases of expensive medical instruments, which seems to be extended to the drug purchasing deals as w...
First new drug by domestic research soon to come out.
The introduction of the first NCE (new chemical entity) drug in Korea appears to speed up by SK pharmaceutical company, and for the same race Dongwha and Daewoong closely followed.
Pacific pharmaceutical announced ...
KPMA forms task-force for amelioration of drug pricing system
The KPMA decided to suggest the ideal amelioration plan for the drug insurance price system to the health ministry since the forthcoming government massive price reduction on insurance drugs had to be delayed. For thi...
Insurance drug pricing guidelines on imported drugs to be readjusted.
The insurance reimbursement price guideline on imported drugs seems to be readjusted to accept compromising price determination based on the current market prices.
The Expert Commission for Medical Insurance Drug P...
Foreign drug corporations against insurance price policy.
The MOHW adjusted prices of 917 imported drugs and called for price confirmations by inviting the foreign multinational drug companies between June 7 and 8, which was the second time program for drug importers to insp...
Low import drug pricing may hamper entry of new drugs.
Due to unreasonable price policy on the imported drugs currently proceeded in the government a new drug especially in use of difficult diseases seems hardly to be introduced into Korean market. The government insuranc...
